Policies and Guidelines
When you submit a manuscript to Biotech Express, we will take it to imply that the manuscript has not already been published or submitted elsewhere. If similar or related work has been published or submitted elsewhere, then you must provide a copy with the submitted manuscript. You may not submit your manuscript elsewhere while it is under consideration at Biotech Express.
The primary affiliation for each author should be the institution where the majority of their work was done. If an author has subsequently moved, the current address may also be stated.
We reserve the right to reject a paper even after it has been accepted if it becomes apparent that there are serious problems with its scientific content, or our publishing policies have been violated.
Peer review policy
The practice of peer review is to ensure that only good science is published. All contributions submitted to Biotech Express that are selected for peer review are sent to one or more independent reviewers, selected by the editors. Authors are welcome to suggest suitable independent reviewers and may also request that the journal excludes one or two individuals or laboratories. The journal sympathetically considers such requests and usually honours them, but the editor’s decision on the choice of referees is final. A final decision to accept or reject the manuscript will be sent to the author along with any recommendations made by the referees, and may include verbatim comments by the referees. Referees advise the editor, who is responsible for the final decision to accept or reject the article.
Editors, authors and reviewers are required to keep confidential all details of the editorial and peer review process on submitted manuscripts. Unless otherwise declared as a part of open peer review, the peer review process is confidential and conducted anonymously; identities of reviewers are not released. Reviewers must maintain confidentiality of manuscripts. If a reviewer wishes to seek advice from colleagues while assessing a manuscript, the reviewer must consult with the editor and should ensure that confidentiality is maintained and that the names of any such colleagues are provided to the journal with the final report. Regardless of whether a submitted manuscript is eventually published, correspondence with the journal, referees’ reports and other confidential material must not be published, disclosed or otherwise publicised without prior written consent. Reviewers should be aware that it is our policy to keep their names confidential and that we do our utmost to ensure this confidentiality. We cannot, however, guarantee to maintain this confidentiality in the face of a successful legal action to disclose identity. Biotech Express reserves the right to contact funders, regulatory bodies, journals and the authors’ institutions in cases of suspected research or publishing misconduct.
Biotech Express is monthly periodical, publishes online and print on 15th of every month. The content submission deadline is 10th of every month or 14th in emergent situation.
Describes the rights related to the publication and distribution of research in Biotech Express. It governs how authors (as well as their employers or funders), publishers and the wider general public can use, publish and distribute articles or books.
Biotech Express requires authors to assign publication rights to Biotech Express as a condition of publishing the work. Biotech Express relies on either an assignment of copyright with permanent rights reserved to the author, or an equivalent grant of a license. Biotech Express treats the rights granted as the basic means of obtaining certain exclusive publication rights; to create and deliver the Digital Library; to further disseminate works by acting as a single source for republication requests, such as aggregated collections or translations, and the delivery of the material to the requesting party; to protect works from plagiarism and any other unauthorized uses; and to sustain and develop its publishing program by selling subscriptions or charging for access to its collections. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.
Biotech Express requires that authors have the authority to grant rights by copyright or license agreements, or that they obtain the necessary authorization to execute the grant of rights. Such grant applies to any medium used by Biotech Express for publication. Both the Biotech Express Copyright Transfer and the Biotech Express Publishing License Agreement leave important rights with the original owner.
The author’s grant of rights applies only to the work as a whole, and not to any embedded objects owned by third parties. An author who embeds an object, such as an art image that is copyrighted by a third party, must obtain that party’s permission to include the object, with the understanding that the entire work may be distributed as a unit in any medium. The requirement to obtain third-party permission does not apply if the author embeds only a link to the copyright holder’s object.
Authors who wish to embed a component of another Biotech Express -copyrighted or licensed work, e.g., an excerpt, a table, or a figure, must obtain an explicit permission (there is no fee) from Biotech Express.